Response by Bagai et al to Letter Regarding Article, “Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention”
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 11, 2016
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Acute Coronary Syndrome (MeSH)
- Aspirin (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Drug Therapy, Combination (MeSH)
- Humans (MeSH)
- Percutaneous Coronary Intervention (MeSH)
- Platelet Aggregation Inhibitors (MeSH)
- Ticlopidine (MeSH)
published in
- Circulation Journal